Perioperative changes in respiratory impedance in lobectomy and their clinical impact. by KAKU Ryosuke et al.
Perioperative changes in respiratory impedance
in lobectomy and their clinical impact.
著者 KAKU Ryosuke, YODEN Makoto, SHIRATORI Takuya,
HAYASHI Kazuki, OKAMOTO Keigo, OHSHIO
Yasuhiko, NAKANO Yasutaka, HANAOKA Jun
journal or
publication title







This is an Open Access article
distributed in accordance with the Creative Commons
Attribution-NonCommercial-NoDerivs 4.0 International
License (CC BY-NC-ND 4.0), which permits the noncommercial
replication and distribution of the article with the strict proviso that no changes or edits are made
and the original work is properly cited (including links to both the formal publication through the
relevant DOI and the license).
See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2021;13(3):1347-1357 | http://dx.doi.org/10.21037/jtd-20-3090
Original Article
Perioperative changes in respiratory impedance in lobectomy and 
their clinical impact
Ryosuke Kaku1, Makoto Yoden1, Takuya Shiratori1, Kazuki Hayashi1, Keigo Okamoto1, Yasuhiko Oshio1, 
Yasutaka Nakano2, Jun Hanaoka1
1Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Shiga, Japan; 2Division of Respiratory 
Medicine, Department of Internal Medicine, Shiga University of Medical Science, Shiga, Japan
Contributions: (I) Conception and design: R Kaku; (II) Administrative support: J Hanaoka; (III) Provision of study materials or patients: All authors; (IV) 
Collection and assembly of data: R Kaku, M Yoden; (V) Data analysis and interpretation: R Kaku, J Hanaoka; (VI) Manuscript writing: All authors; (VII) 
Final approval of manuscript: All authors. 
Correspondence to: Ryosuke Kaku, MD. Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Seta 
Tsukinowa-cho, Otsu, Shiga 520-2192, Japan. Email: kakutin@belle.shiga-med.ac.jp.
Background: Respiratory function declines after lung resection. However, perioperative changes in 
respiratory impedance and their clinical significance are unclear. The forced oscillation technique can 
measure respiratory impedance during quiet breathing and possibly early after surgery. We investigated 
respiratory impedance changes before and after lung lobectomy and examined the correlation of impedance 
with clinical factors. 
Methods: We prospectively included patients who underwent lobectomy between February 2018 and 
March 2020 and measured respiratory impedance by forced oscillation preoperatively and postoperative 
days 1 and 7. We statistically analyzed changes in perioperative forced oscillation measurements and their 
correlation with clinical factors, including subjective symptoms. The modified British Medical Research 
Council scale and the chronic obstructive pulmonary disease (COPD) assessment test were used for scoring 
subjective symptoms.
Results: Forty-four subjects were included, in whom respiratory impedance could be measured from 
postoperative day 1. The respective mean values for forced oscillation measurements preoperatively and at 
postoperative days 1 and 7 were as follows: respiratory resistance, 5 Hz: 2.28, 2.77, and 2.75; respiratory 
resistance, 20 Hz: 2.00, 2.36, and 2.32; difference in respiratory resistance at 5 and 20 Hz: 0.28, 0.40, and 
0.43; respiratory reactance, 5 Hz: −0.31, −0.65, and −0.56; resonant frequency: 7.45, 10.41, and 9.81; and 
low-frequency reactance area: 1.33, 3.27, and 2.84. These changes were statistically significant (P<0.01). 
Besides the difference in respiratory resistance at 5 and 20 Hz, all other measurements on postoperative 
day 7 were relatively weakly correlated with the modified Medical Research Council scale score at this time 
point (all P<0.05). Respiratory complications correlated with the respiratory resistance difference, respiratory 
reactance, and resonant frequency on day 7 (R =0.415, −0.421, and 0.441), while the latter also correlated 
with postoperative hypoxemia on day 1 (R =0.433).
Conclusions: Respiratory impedance was measurable even early after surgery and significantly changed 
postoperatively. As the sample size was small and appeared to be biased, assessing respiratory impedance and 
clinical factors in detail was difficult. Since respiratory impedance is suggested to be associated with clinical 
factors that affect the postoperative course, it is necessary to accumulate cases and observe them over longer 
periods.
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Introduction
Pulmonary function declines after lung surgery. However, 
this is difficult to assess with spirometry because it requires 
the patient’s maximum exhalation effort, which is hindered 
early after surgery due to pain, cough, and sputum. The 
forced oscillation technique (FOT) is a non-invasive method 
for measuring lung mechanics (1) and can be applied even 
in patients with difficulty with spirometry. 
In the FOT, respiratory impedance (Zrs) is measured 
by the airflow and pressure returning from the periphery 
of the lung when the forced oscillation is applied from the 
mouth. Zrs is expressed using respiratory resistance (Rrs) 
and respiratory reactance (Xrs) as follows: (Zrs)2 = (Rrs)2 + 
(Xrs)2. Rrs corresponds to the viscous resistance and mainly 
reflects airway resistance (Raw), whereas Xrs corresponds to 
elasticity and inertia and reflects the lung stiffness and the 
difficulty of air entering the lungs (1,2). Some consider that 
Rrs at 5 Hz (R5) represents total Raw, that Rrs at 20 Hz 
(R20) represents central Raw, and that the difference 
between R5 and R20 (R5-R20) represents peripheral Raw 
(3,4); however, there is no physiological basis for these 
considerations (1). R5-R20 is only a frequency dependence 
of Rrs. The point at which Xrs = 0 is referred to as resonant 
frequency (Fres) and the integral of Xrs at 5 Hz (X5) to 
the Fres is referred to as the low-frequency reactance 
area (ALX). X5, Fres, and ALX are frequently used as a 
representative marker of Xrs (1). Previous studies have 
reported that R5, R5-R20, and Fres are higher, and X5 is 
lower in patients with obstructive pulmonary ventilation 
disorders such as asthma and chronic obstructive pulmonary 
disease (COPD) than in healthy controls (5,6). In addition, 
R20 was found to be most important in the severity of 
asthma, poor control, quality of life, and exacerbation 
frequency (7). Another study suggested Fres as a marker of 
lung fibrosis in patients with interstitial lung disease (8,9).
MostGraph 02 (Chest M.I., Inc., Tokyo, Japan) can 
measure Rrs and Xrs in a moment during tidal breathing 
and may be performed even early after surgery. However, 
it is unclear how the measurement of Zrs changes before 
and after lung surgery and whether the measurement of 
Zrs itself is meaningful for postoperative care. This study 
aimed to clarify Zrs changes in lobectomy and determine 
the clinical relevance of this measurement. We hoped that 
if adverse events such as respiratory failure and pneumonia 
could be predicted and detected early after surgery by 
assessing Zrs, it would be possible to prevent exacerbations 
and provide early intervention.
Therefore, in this study, we revealed changes in 
Zrs during the perioperative period of lobectomy and 
investigated the correlation of Zrs in the pre- and 
postoperative periods with various clinical factors, such as 
physical characteristics, comorbidities, length of surgery, 
intraoperative blood loss, postoperative complications, and 
subjective symptoms. We present the following article in 




In this prospective observational study, 57 consecutive 
patients scheduled to undergo radical lobectomy for 
non-small cell lung cancer (NSCLC) between February 
2018 and March 2020 were recruited after providing 
informed consent. The principal investigator or the 
research coordinator was responsible for maintaining 
the respondents’ anonymity. The study was conducted in 
accordance with the Declaration of Helsinki (as revised in 
2013). The study was approved by the ethics board of Shiga 
University of Medical Science (NO.: R2017-185; December 
25, 2017) and written informed consent was obtained from 
each participant.
Patients who were not indicated for lobectomy, 
those who had difficulty in preoperative MostGraph 
measurements, those who had a history of lung surgery, or 
those who required bilobectomy or total pneumonectomy 
were excluded from the study.
Surgical procedures and perioperative management
Thoracotomy or thoracoscopic surgery was performed. 
In cases without a preoperative diagnosis, needle biopsy 
or pulmonary wedge resection was performed during 
surgery, followed by radical lobectomy and lymph node 
dissection if a definitive diagnosis of lung cancer was 
obtained by intraoperative rapid pathological examination. 
At the end of the surgery, two drains were placed in the 
thoracic cavity to observe bleeding and air leakage and were 
subsequently removed after postoperative day 1 (POD1). 
For pain, epidural anesthesia or intravenous patient-
controlled analgesia was performed; oral administration of 
acetaminophen and non-steroidal anti-inflammatory drugs 
was started from POD1, and only oral analgesics were taken 
after removal of the chest drain.
1349Journal of Thoracic Disease, Vol 13, No 3 March 2021
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2021;13(3):1347-1357 | http://dx.doi.org/10.21037/jtd-20-3090
Measurement of Zrs
R5, R20, R5-R20, X5, Fres, and ALX were measured before 
the operation and at PODs 1 and 7, and the values were 
compared. Measurements were performed using MostGraph 
02 (Chest M.I., Inc., Tokyo, Japan) as follows. In the sitting 
position, with the neck in a comfortable neutral posture and 
wearing a nose clip, the subjects supported their cheeks to 
eliminate upper airway shunting during the measurements. 
The examiner confirmed the respiratory waveform during 
measurement and selected the one with the lowest R5 out 
of three series with stable waveforms.
Subjective symptoms
We used the modified British Medical Research Council 
(mMRC) scale and the COPD assessment test (CAT) as 
scales of subjective symptoms (10-14). Dyspnea on exertion 
was evaluated by mMRC on a scale of 5, from 0 to 4. 
Although CAT is used for scoring the respiratory status 
of patients with COPD from 0 to 5 points by evaluating 
eight items, we used three items, i.e., cough, sputum, and 
dyspnea, which can be evaluated during hospitalization, as 
the modified CAT (mCAT). 
Data collection
Clinical factors were defined as follows: subjective 
symptoms (mMRC and mCAT scores), preoperative 
factors [age, sex, height, weight, Brinkman Index (B.I.), 
clinical stage, induction therapy, medical history, and 
preoperative spirometry measurements], perioperative 
factors (thoracotomy approach, excision cite, number of 
resection segments, length of surgery, blood loss, weight 
gain rate, duration of the chest drainage, postoperative 
hospital stay, and pathological stage), and postoperative 
complications. Stage was determined using the 8th edition 
of TNM classification for lung cancer (15). The number of 
resection segments was calculated as five segments in the 
left upper lobe. Postoperative complications were evaluated 
by the Common Terminology Criteria for Adverse Events 
(CTCAE) version 5.0 (16).
Statistical analysis
All results are expressed as mean ± standard deviation (SD). 
Statistical analysis was performed using SPSS version 22 
(SPSS Inc., Chicago, IL, USA). Perioperative R5, R20, 
R5-R20, X5, Fres, and ALX were tested for normality by 
the Shapiro-Wilk test. For normally distributed variables, 
the parametric paired t-test was used to obtain statistically 
significant differences in changes in these variables before 
and after the operation. For non-normally distributed 
variables, the non-parametric Wilcoxon signed-rank test 
was used. 
The correlation between the measured Zrs and mMRC 
score was examined by Spearman’s rank correlation test, 
while the correlation with clinical factors other than the 
mMRC score was tested by Pearson’s correlation analysis. P 
values <0.05 were considered as statistically significant.
Subgroup analysis
We enrolled patients without respiratory disease into 
the control group, and patients with a history of COPD, 
interstitial pneumonia (IP), and combined pulmonary 
fibrosis and emphysema (CPFE) into subgroups, and 
compared Zrs measurements at each time point. 
Normally distributed variables were tested for 
homoscedasticity with the Levene test. One-way ANOVA 
was used for homoscedastic distributed variables to obtain 
statistically significant differences in subgroups at each 
time point. For non-homoscedastic distributed variables, 
Welch’s t-test was performed; for non-normally distributed 
variables, the Kruskal-Wallis test was used.
We similarly divided the surgical procedure into 
subgroups comprising video-assisted thoracic surgery 
(VATS) and thoracotomy and compared the measured Zrs 
values at each measurement time point. The independent 
t-test was used for normally distributed variables, and 
Welch’s t-test was used for non-normally distributed 
variables to obtain a significant difference.
Results
The study included 57 patients who provided consent to 
participate. From a total of 11 patients without lung cancer 
who were diagnosed with benign illnesses by intraoperative 
rapid pathological examination, one declined to participate 
in the study after surgery, and one was discharged on POD6. 
These patients were consequently excluded from the study. 
Thus, 44 patients (35 male, 9 female; age: mean ± SD, 
69.2±10.3 years) were included in the analysis (table online: 
https://cdn.amegroups.cn/static/public/jtd-20-3090-1.xlsx). 
Rrs and Xrs were measurable by MostGraph on POD1 
in all 44 patients analyzed. 
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The preoperative clinical factors are shown in Table 1. 
Thirty-four patients (77.3%) had a history of smoking, and 
the mean B.I. was 628.0±618.6. Thirty-nine patients had 
preoperative comorbidity, and 19 (43.2%) had respiratory 
diseases; of the latter, 11 (25.0%) had COPD, 5 (11.4%) 
had IP, and 3 (6.8%) had combined pulmonary fibrosis and 
emphysema. Moreover, 35 patients were at clinical stage 1, 
accounting for 79.5% of the study participants. 
Perioperative factors assessed during the present study 
are illustrated in Table 2. The surgical approach included 
VATS in 38 patients (86.4%) and thoracotomy in 6 patients 
(13.6%). Right upper lobectomy was the most common 
surgery (16 patients, 36.4%). The mean length of surgery 
was 299.0±74.6 min, and the mean bleeding volume was 
87.9±141.7 mL. The mean length of postoperative hospital 
stays was 9.9±4.5 days. Most patients were in the early 
pathological stage (36 were at stage 1, 4 were at stage 2, 
and 4 were at stage 3). Postoperative complications of all 
CTCAE grades were observed in 30 patients (68.2%), with 
atelectasis being the most common (18 patients, 40.9%), 
followed by coughing requiring antitussive drugs (15 patients, 
34.1%). Postoperative complications of CTCAE grade 2 
and 3 were observed in 11 patients (25.0%) and 1 (2.3%) 
patient, respectively. Among these, CTCAE grade 2 or 
higher respiratory complications was observed in 8 patients 
(18.2%), as follows: pneumonia in 3 patients (6.8%), 
hypoxemia in 4 (9.1%), atelectasis requiring bronchoscopy 
in 1 (2.3%), and prolonged pulmonary fistula in 1 (2.3%) 
patient.
Perioperative changes in Zrs
Changes in FOT measurements before and after surgery are 
shown in Figure 1 and Table 3. The mean values of all FOT 
measurements changed significantly at POD1 and POD7 
compared to the respective preoperative values. Specifically, 
R5, R20, R5-R20, Fres, and ALX significantly increased, 
whereas X5 significantly decreased postoperatively (P<0.05). 
From POD1 to POD7, only the mean value of X5 improved 
significantly (P=0.018).
In the subgroup analysis of respiratory disease, at most 
time points, there was no significant difference in FOT 
measurements between the subgroups, but there was a 
significant difference in X5, Fres, and ALX on POD1 
(P=0.035, 0.045, and 0.034, respectively; Figure 2).
In the subgroup analysis of the surgical procedure, there 
was no significant difference at any time point for any 
measurement.
Table 1 Preoperative factors
Preoperative factors N (%) or mean ± SD
N 44
Age (years) 69.2±10.3
Sex (male/female) 35 (79.5)/9 (20.5)
Height (cm) 165.0±8.0
Body weight (kg) 62.4±8.1
Smoker 34 (77.3)











Preoperative comorbidity 38 (86.4)




Cardiovascular disease 26 (59.1)











Values are presented as frequency (%) or mean ± standard  
deviation (SD). SD, standard deviation; COPD, chronic obstructive 
pulmonary disease; IP, interstitial pneumonia; CPFE, combined 
pulmonary fibrosis and emphysema; VC, vital capacity; %VC, 
measured vital capacity/predicted vital capacity ×100; FEV1.0, forced 
expiratory volume in 1 second; FEV1.0%, forced expiratory volume 
% in 1 second; %FEV1.0, measured forced expiratory volume in 1 
second/predicted forced expiratory volume in 1 second ×100.
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Perioperative changes in subjective symptoms 
Changes in mMRC and mCAT scores before and after 
surgery are shown in Figure 3. Preoperatively, 36 (81.8%) 
patients scored 0 on the mMRC scale, and 8 (18.2%) scored 
1. On POD1, 2 (4.5%) patients scored 0, 20 (45.5%) scored 
1, 12 (27.3%) scored 2, 6 (13.6%) scored 3, and 4 (9.1%) 
scored 4. On POD7, 13 (29.5%) scored 0, 23 (52.3%) 
scored 1, 6 (13.6%) scored 2, 1 (2.3%) scored 3, and 1 
(2.3%) scored 4. The mean mMRC score significantly 
increased from 0.18±0.39 preoperatively to 1.77±1.05 on 
POD1 (P=0.000) and 0.95±0.86 on POD7 (P=0.000). A 
significant change was also noted from POD1 to POD7 
(P=0.000) (Figure 3).
The mean mCAT score significantly increased from 
1.86±2.13 preoperatively to 4.30±2.38 and 3.98±2.54 
on POD1 and POD7, respectively (both P=0.000). No 
improvement was noted from POD1 to POD7 (P=0.417) 
(Figure 3). 
Correlation between Zrs and clinical factors
Subjective symptoms
On POD7, R5, R20, X5, Fres, and ALX relatively weakly 
correlated with the corresponding mMRC score at this time 
point (rS =0.315, 0.304, −0.299, 0.314, and 0.324), but no 
other significant correlation was observed.
Other factors 
Table 4 shows the statistically significant correlations 
between Zrs and clinical factors. Preoperative factors 
correlating with Zrs included age, sex, height, smoking 
history, B.I., and spirometry parameters [vital capacity (VC), 
%VC, forced expiratory volume during the first second 
Table 2 Perioperative factors
Perioperative factors N (%) or mean ± SD







Length of surgery (min) 299.0±74.6
Blood loss (mL) 87.9±141.7
Body weight change rate (POD1) (%) 1.65±1.27
Body weight change rate (POD7) (%) −0.21±1.87
Postoperative hospital stay 9.9±4.5









Postoperative complications 30 (68.2)
Respiratory complications 23 (52.3)
Pneumonia 3 (6.8)
Atelectasis (with/without BF) 18 (40.9)  
[1 (2.3)/17 (38.6)]
Sputum (need to take expectorants) 6 (13.6)
Hypoxemia (HOT) 4 (9.1)
Cough (need to take antitussives) 15 (34.1)
Cardiovascular complications 6 (13.6)
Ischemic heart disease None
Arrhythmia 5 (11.4)
Thrombosis 1 (2.3)
Technical complications 4 (9.1)
Prolonged pulmonary fistula 1 (2.3)
Table 2 (continued)
Table 2 (continued)
Perioperative factors N (%) or mean ± SD
Chylothorax 1 (2.3)
Recurrent laryngeal nerve palsy 2 (4.5)
Others 3 (6.8)
Postoperative death None
SD, standard deviation; VATS, video-assisted thoracic surgery; 
VC, vital capacity; LLL, left lower lobe; LUL, left upper lobe; 
RLL, right lower lobe; RML, right middle lobe; RUL, right upper 
lobe; BF, bronchofiberoscopy; HOT, home oxygen therapy.
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R5 (cmH2O/L/s)
X5 (cmH2O/L/s) Fres (Hz)
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Figure 1 Changes in forced oscillatory parameters during the perioperative period. Values are presented as mean ± standard deviation. After 
surgery, R5, R20, R5-R20, Fres, and ALX increased significantly, whereas X5 decreased. No significant changes were observed between 
POD1 and POD7 in any of the parameters. ×: average; -: median. *, P<0.05; **, P<0.01 versus preoperative parameters. +, P<0.05 versus 
POD1. ALX, low-frequency reactance area; Fres, resonant frequency; Rrs, respiratory system resistance; R5 and R20, Rrs at 5 Hz and 20 
Hz; R5-R20, the difference between R5 and R20; Xrs, respiratory system reactance; X5, Xrs at 5 Hz. 
Table 3 Changes in forced oscillatory parameters during the perioperative period
Parameters Preoperative POD1 P value POD7 P value
R5 (cmH2O/L/s) 2.28±0.68 2.77±0.84** 0.000 2.75±0.88** 0.000
R20 (cmH2O/L/s) 2.00±0.60 2.36±0.72** 0.000 2.32±0.72** 0.000
R5-R20 (cmH2O/L/s) 0.28±0.29 0.40±0.33* 0.010 0.43±0.32** 0.000
X5 (cmH2O/L/s) −0.31±0.30 −0.65±0.43** 0.000 −0.56±0.40** 0.000
Fres (Hz) 7.45±2.51 10.41±3.20** 0.000 9.81±3.47** 0.000
ALX (cmH2O/L/s × Hz) 1.33±1.63 3.27±2.94** 0.000 2.84±2.77** 0.000
*, P<0.05; **, P<0.01 versus preoperative scores. ALX, low-frequency reactance area; Fres, resonant frequency; R5, respiratory system 
resistance at 5 Hz; R20, respiratory system resistance at 20 Hz; R5-R20, the difference between R5 and R20; X5, respiratory system  
reactance at 5 Hz; POD, postoperative day. 
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(FEV1.0), %FEV1.0, forced expiratory volume % during 
the first second (FEV1.0%)]. Perioperative factors showing 
significant correlation with impedance included the number 
of resection segments, blood loss, body weight gain rate, and 
respiratory complications of CTCAE grade 1 and above. In 
contrast, there was no significant correlation of Zrs with the 
surgical approach, length of surgery, and excision site. 
Many of the observed correlations were relatively weak. 
Factors showing a moderate correlation, with an absolute 
correlation coefficient (R) value of 0.4 or more are described 
below.
All clinical factors, |R| ≥0.4
Age was positively correlated with the preoperative R5-R20 (R 
=0.478). Male sex and height were negatively correlated with 
the preoperative R5 and R20 (male sex: R =−0.418, −0.643, 
respectively; height: R =−0.460 and −0.489, respectively; 
Table 4). There was a relatively strong negative correlation 
of preoperative VC and FEV1.0 with the preoperative R5 
and R20 (VC: R =−0.621 and −0.571, respectively; FEV1.0: R 
=−0.610 and −0.529, respectively; Table 4).
There was a negative correlation between the number 
of resection segments and R20 on POD1 (R =−0.445) and a 
positive correlation between blood loss and R5 and R5-R20 
on POD1 (R =0.465 and 0.456, respectively). 
All respiratory complications, including atelectasis 
without treatment or medication, were positively correlated 
with R5-R20 and Fres on POD7 (R =0.415 and 0.441, 
respectively) and negatively correlated with X5 (R =−0.421) 
on POD7. Postoperative hypoxemia and cough for 
which antitussives were administered were positively and 
negatively correlated with Fres on POD1 (R =0.433 and 
−0.459, respectively). The correlation of Zrs with atelectasis, 
pneumonia, and sputum was insignificant (|R| ≥0.4).
Discussion
To the best of our knowledge, the Zrs in lung resection has 
R5 (cmH2O/L/s)
X5 (cmH2O/L/s) Fres (Hz)
R20 (cmH2O/L/s) R5-R20 (cmH2O/L/s)
ALX (cmH2O/L/s × Hz)
Control       COPD       IP       CPFE
P            0.857             0.718              0.569
P               0.328            0.035*             0.412
            0.063               0.824              0.295
              0.130             0.045*            0.295               0.274             0.034*            0.456
             0.131             0.203              0.561
Preoperative        POD1             POD7
Preoperative         POD1             POD7
Preoperative       POD1             POD7
Preoperative        POD1             POD7 Preoperative        POD1             POD7
Preoperative      POD1             POD7
Control       COPD       IP       CPFE
Control       COPD       IP       CPFE
Control       COPD       IP       CPFE
Control       COPD       IP       CPFE








































Figure 2 Changes in forced oscillatory parameters during the perioperative period in respiratory disease subgroups. Values are presented 
as mean ± standard deviation. There was no significant difference in FOT measurements between the subgroups, but significant differences 
were noted in X5, Fres, and ALX on POD1. ×: average; -: median. *, P<0.05, POD1 versus POD7. R5 and R20, Rrs at 5 Hz and 20 Hz; 
R5-R20, the difference between R5 and R20; ALX, low-frequency reactance area; CPFE, combined pulmonary fibrosis and emphysema; 
COPD, chronic obstructive pulmonary disease; Fres, resonant frequency; IP, interstitial pneumonia; X5, Xrs at 5 Hz. 
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not been examined. This study’s primary purpose was to 
clarify the change in Zrs during the perioperative period 
of lobectomy and examine the relationship of Zrs with 
clinical factors. After surgery, FOT parameters other than 
X5 significantly increased, whereas X5 decreased on POD1 
and POD7. There were 29 combinations of clinical factors 
correlating with Zrs, but nearly half of those combinations 
had only a weak correlation.
Several studies have reported that FOT parameters 
correlate with spirometry (17,18). Nikkuni and colleagues 
measured Zrs and spirometry preoperatively and 2 weeks after 
esophageal surgery and reported that changes in FVC and 
FEV1.0 were significantly correlated with changes in R5 (19). 
Consistently, we found that preoperative VC and FEV1.0 
correlated with almost all preoperative Zrs parameters, 
suggesting that Rrs depends on the lung volume. In this 
study, postoperative spirometry was not measured because 
of the difficulty in obtaining accurate measurements due to 
the patients’ postoperative pain and cough. Since lobectomy 
decreases VC and FEV1.0 according to the amount of 
resection, we consider that changes in Rrs were caused by 
a decrease in the lung volume. In addition, the following 
conditions may be present during the perioperative period: 
(I) airway obstruction due to increased sputum, (II) increased 
tissue resistance due to edematous changes in lung tissue and 
bronchi, (III) postoperative decrease in chest-wall compliance 
due to pain and chest closure, and (IV) uneven ventilation 
due to changes in intrathoracic pressure. The loss of lung 
volume and these conditions may have affected respiratory 
impedance. However, since there are many confounding 
factors, it may be necessary to examine it in combination with 
other evaluation factors, such as spirometry and computed 
tomography (CT).
Subjective symptoms are one of the most clinically 
important factors in assessing the usefulness of Zrs 
measurements before and after lung resection. Subjective 
symptom scores based on the mMRC and mCAT scores 
increased after surgery. However, while the mMRC score 
improved rapidly from POD1 to POD7, the mCAT score 
did not improve by POD7. After surgery, mMRC score, 
which shows only dyspnea on exertion, may have improved 
in a short period by removing the chest drainage tube. 
However, sputum and cough, which persisted, were also 
considered in the mCAT score; therefore, improvement 
may have been insufficient. In POD7, Zrs measurements, 
other than R5-R20, showed a relatively weak correlation 
with the mMRC score. Unfortunately, it was difficult to 
correlate subjective symptoms with Zrs because the mMRC 
score can be affected by postoperative complications.
This study found a positive correlation between 
intraoperative blood loss and R5 and R5-R20 on POD1. 
Rrs, especially R5, represents the airway diameter (1), 
which can be affected by edematous changes in the airways 
and bronchial obstruction with sputum or bloody sputum. 
The circulating plasma volume is usually decreased due 
to surgery and anesthesia, leading to edema (20-23), and 
increased bleeding increases intraoperative fluid volume and 
anesthesia time, resulting in increased edema. Therefore, 
it was considered that the intraoperative bleeding amount 
was correlated with R5 and R5-R20 on POD1. Improved 
weight gain on POD7 showed improved diuresis and 
edema, consistent with no correlation between R5 and R5-
R20 at this time point. Airway narrowing due to edema 
and sputum can cause respiratory complications, such 
as atelectasis, pneumonia, and hypoxemia. Thus, early 


























Figure 3 Changes in subjective symptoms’ scores during the perioperative period. Values are presented as mean ± standard deviation. After 
surgery, both the mMRC and mCAT scores increased. The mMRC score significantly improved from POD1 to POD7, whereas the mCAT 
score did not change. ×: average; -: median. **, P<0.01 versus preoperative scores; ++, P<0.01, POD1 versus POD7. mCAT, modified COPD 
assessment test; COPD, chronic obstructive pulmonary disease; mMRC, modified Medical Research Council.
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Table 4 Significant correlations between forced oscillatory parameters 
and clinical factors
Factors Measured value R P value
Preoperative factors
Age R5-R20pre 0.478** 0.001
Male sex R5pre −0.418** 0.005
R20pre −0.643** 0.000
R5-R20pre 0.340** 0.024
Height R5pre −0.460** 0.002
R20pre −0.489** 0.001









%VC R5-R20pre −0.310* 0.041
X5pre 0.298* 0.049
Frespre −0.305* 0.044
FEV1.0 R5pre −0.610** 0.000
R20pre −0.529** 0.000
R5-R20pre −0.347** 0.009
%FEV1.0 R5-R20pre −0.317** 0.036
Perioperative factors






Blood loss R5POD1 0.465** 0.001
R20POD1 0.329* 0.029
R5-R20POD1 0.456** 0.002

















Atelectasis R5-R20POD7 0.326* 0.031
Hypoxemia (HOT) FresPOD1 0.433** 0.003
FresPOD7 0.361* 0.016









*, P<0.05; **, P<0.01 (Pearson correlation analysis). ALX, low-
frequency reactance area; B.I., Brinkman index; CTCAE, Common 
Terminology Criteria for Adverse Events; FEV1.0, forced expiratory 
volume in 1 second; %FEV1.0, measured forced expiratory volume 
in 1 second/predicted forced expiratory volume in 1 second ×100; 
VC, vital capacity; %VC, measured vital capacity/predicted vital 
capacity ×100; Fres, resonant frequency; HOT, home oxygen 
therapy; R, correlation coefficient; R5, respiratory system resistance 
at 5 Hz; R20, respiratory system resistance at 20 Hz; R5-R20, the 
difference between R5 and R20; X5, respiratory system reactance 
at 5 Hz; POD, postoperative day. 
infiltrative shadows and symptoms on chest radiography 
enables early therapeutic intervention that may contribute 
to a better prognosis.
We initially thought it would be beneficial for patients if 
we could predict or diagnose postoperative complications 
early by measuring Zrs. However, in reality, few postoperative 
complications required treatment, and many were 
insignificant, so the expected results were not obtained. 
However, on POD1, Fres was moderately correlated with 
hypoxemia and cough requiring antitussives. In particular, 3 
out of 4 patients with postoperative hypoxemia had a history of 
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IP. Considering that Fres is a marker of pulmonary fibrosis in 
IP (8,9), the increase in Fres in the early postoperative period 
may predict hypoxemia in patients with IP and useful for early 
intervention after surgery. Although the number of patients in 
each subgroup of respiratory disease was small, the subgroup 
analysis results of Zrs provided limited support to this 
hypothesis. Fortunately, no postoperative acute exacerbation of 
IP was observed in this study, but the fatality rate is high when 
it develops, and early diagnosis and treatment are important. 
In this regard, measuring Zrs can be advantageous.
This study has several limitations. First, only univariate 
analysis has been performed, and confounding factors 
contributing to changes in FOT parameters cannot be 
excluded. Zrs strongly correlates with physiological factors 
such as age, sex, and height; however, the prediction equation 
itself has not been established, and there were no specific 
reference values for MostGraph (1,24,25), so it is difficult to 
evaluate it by comparing simple numerical values. Another 
bias is that different individuals feel pain differently, and chest 
tube removal timing also differs between patients. Second, 
this study was limited to lobectomy and included only cases 
with a pulmonary function that could tolerate lobectomy, and 
thus cases with a poor general condition in which lobectomy 
could not be performed were not included. As preoperative 
comorbidities vary widely, there may be no significant 
correlation between preoperative comorbidities and 
perioperative Zrs changes. Finally, this study was conducted 
in a single-center, and the sample size was small.
In conclusion, this study clarified changes in Zrs during 
the perioperative period of radical lobectomy for lung 
cancer and the correlation between Zrs and other clinical 
factors. Zrs parameters were different postoperatively, 
but its measurement did not predict or diagnose early 
postoperative complications. However, some Zrs parameters 
were correlated with clinical factors associated with the 
clinical course. In particular, Fres on POD1 was correlated 
with hypoxia, which may be an important predictor of 
early detection of hypoxemia and acute exacerbation in 
patients with IP. There are many confounding factors, 
and the exact clinical factor associated with a specific Zrs 
parameter remains unclear. Eliminating confounders is 
difficult; however, the postoperative course can be further 
enhanced by analyzing more cases and comparing changes 
in Zrs over a longer period using conventional spirometry, 
combined with anatomical evaluations by CT. Further, 
because MostGraph could measure Zrs even in the early 
postoperative period, we expect that MostGraph can be 
used in the future for evaluating respiratory function in the 
early postoperative period instead of spirometry.
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